Kohsaka H - Search Results

1

A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.

Sugihara T, Sekine C, Nakae T, Kohyama K, Harigai M, Iwakura Y, Matsumoto Y, Miyasaka N, Kohsaka H. Sugihara T, et al. Among authors: kohsaka h. Arthritis Rheum. 2007 Apr;56(4):1304-14. doi: 10.1002/art.22521. Arthritis Rheum. 2007. PMID: 17394136 Free article.

2

Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.

Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H. Okiyama N, et al. Among authors: kohsaka h. Arthritis Rheum. 2009 Aug;60(8):2505-12. doi: 10.1002/art.24689. Arthritis Rheum. 2009. PMID: 19644888 Free article.

3

Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis.

Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N, Kohsaka H. Sugihara T, et al. Among authors: kohsaka h. Arthritis Rheum. 2010 Oct;62(10):3088-92. doi: 10.1002/art.27625. Arthritis Rheum. 2010. PMID: 20583106 Free article.

4

Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.

Sugihara T, Okiyama N, Watanabe N, Miyasaka N, Kohsaka H. Sugihara T, et al. Among authors: kohsaka h. Arthritis Rheum. 2012 Aug;64(8):2655-62. doi: 10.1002/art.34465. Arthritis Rheum. 2012. PMID: 22392010 Free article.

5

T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model.

Okiyama N, Sugihara T, Oida T, Ohata J, Yokozeki H, Miyasaka N, Kohsaka H. Okiyama N, et al. Among authors: kohsaka h. Arthritis Rheum. 2012 Nov;64(11):3741-9. doi: 10.1002/art.34629. Arthritis Rheum. 2012. PMID: 22806443 Free article.

6

Interferon-γ, but Not Interleukin-4, Suppresses Experimental Polymyositis.

Yoshihashi-Nakazato Y, Kawahata K, Kimura N, Miyasaka N, Kohsaka H. Yoshihashi-Nakazato Y, et al. Among authors: kohsaka h. Arthritis Rheumatol. 2016 Jun;68(6):1505-10. doi: 10.1002/art.39592. Arthritis Rheumatol. 2016. PMID: 26815159

7

Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice.

Suzuki F, Nanki T, Imai T, Kikuchi H, Hirohata S, Kohsaka H, Miyasaka N. Suzuki F, et al. Among authors: kohsaka h. J Immunol. 2005 Nov 15;175(10):6987-96. doi: 10.4049/jimmunol.175.10.6987. J Immunol. 2005. PMID: 16272359

8

Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.

Nonomura Y, Nagasaka K, Hagiyama H, Sekine C, Nanki T, Tamamori-Adachi M, Miyasaka N, Kohsaka H. Nonomura Y, et al. Among authors: kohsaka h. Arthritis Rheum. 2006 Jul;54(7):2074-83. doi: 10.1002/art.21927. Arthritis Rheum. 2006. PMID: 16802342 Free article.

9

Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.

Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H. Murakami Y, et al. Among authors: kohsaka h. Arthritis Rheum. 2009 Jun;60(6):1615-23. doi: 10.1002/art.24554. Arthritis Rheum. 2009. PMID: 19479878 Free article.

10

Expression of CD45 isoforms correlates with differential proliferative responses of peripheral CD4+ and CD8+ T cells.

Seki I, Suzuki M, Miyasaka N, Kohsaka H. Seki I, et al. Among authors: kohsaka h. Immunol Lett. 2010 Mar 10;129(1):39-46. doi: 10.1016/j.imlet.2009.12.020. Epub 2010 Jan 20. Immunol Lett. 2010. PMID: 20093141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters